homocysteine and omega-n-methylarginine

homocysteine has been researched along with omega-n-methylarginine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fast, W; Hong, L1
Okatani, Y; Reiter, RJ; Wakatsuki, A1
Ahmed, S; Al-Hesayen, A; Burstein, JM; Gori, T; Kelly, S; Miner, SE; Parker, JD1
Burke, V; Croft, KD; Playford, DA; Watts, GF1
Coote, JH; Smith, L; Yang, Z1
Hayashida, Y; Morishita, T; Nakashima, Y; Nakata, S; Sasaguri, Y; Suda, O; Tasaki, H; Toyohira, Y; Tsujimoto, T; Tsutsui, M; Ueno, S; Ueta, Y; Yanagihara, N1
Allard, SE; Cummings, MH; Laight, DW; Meeking, DR; Munday, LJ; Shaw, KM; Turner, C; Wotherspoon, F1

Trials

3 trial(s) available for homocysteine and omega-n-methylarginine

ArticleYear
Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study.
    Circulation, 2001, Sep-04, Volume: 104, Issue:10

    Topics: Acetylcholine; Adult; Blood Flow Velocity; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Tolerance; Enzyme Inhibitors; Folic Acid; Forearm; Heart Rate; Hematinics; Homocysteine; Humans; Infusion Pumps; Male; Nitric Oxide Synthase; Nitroglycerin; omega-N-Methylarginine; Vasodilator Agents

2001
Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes.
    Atherosclerosis, 2003, Volume: 168, Issue:1

    Topics: Acetylcholine; Antioxidants; Apolipoprotein A-I; Area Under Curve; Blood Circulation; Blood Pressure; Bradykinin; Cholesterol, HDL; Cholesterol, LDL; Coenzymes; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Enzyme Inhibitors; F2-Isoprostanes; Female; Fenofibrate; Forearm; Glycated Hemoglobin; Homocysteine; Humans; Hypolipidemic Agents; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Statistics as Topic; Systole; Treatment Outcome; Triglycerides; Ubiquinone; Vasodilator Agents

2003
The effect of oral folic acid upon plasma homocysteine, endothelial function and oxidative stress in patients with type 1 diabetes and microalbuminuria.
    International journal of clinical practice, 2008, Volume: 62, Issue:4

    Topics: Administration, Oral; Adult; Albuminuria; Blood Flow Velocity; Diabetes Mellitus, Type 1; Endothelium, Vascular; Enzyme Inhibitors; Female; Folic Acid; Forearm; Homocysteine; Humans; Male; omega-N-Methylarginine; Oxidative Stress

2008

Other Studies

4 other study(ies) available for homocysteine and omega-n-methylarginine

ArticleYear
Inhibition of human dimethylarginine dimethylaminohydrolase-1 by S-nitroso-L-homocysteine and hydrogen peroxide. Analysis, quantification, and implications for hyperhomocysteinemia.
    The Journal of biological chemistry, 2007, Nov-30, Volume: 282, Issue:48

    Topics: Amidohydrolases; Amino Acid Sequence; Animals; Binding Sites; Cloning, Molecular; Cysteine; Dose-Response Relationship, Drug; Drug Design; Homocysteine; Humans; Hydrogen Peroxide; Hyperhomocysteinemia; Kinetics; Molecular Sequence Data; Oxidation-Reduction; Sequence Homology, Amino Acid; Substrate Specificity

2007
Protective effect of melatonin against homocysteine-induced vasoconstriction of human umbilical artery.
    Biochemical and biophysical research communications, 2000, Oct-22, Volume: 277, Issue:2

    Topics: Analysis of Variance; Antioxidants; Calcimycin; Cell-Free System; Dinoprost; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Homocysteine; Humans; Ionophores; Iron; Melatonin; Muscle, Smooth; Nitric Oxide; omega-N-Methylarginine; Oxidative Stress; Oxygen; Time Factors; Umbilical Arteries; Vasoconstriction

2000
Paraventricular nucleus activation of renal sympathetic neurones is synaptically depressed by nitric oxide and glycine acting at a spinal level.
    Neuroscience, 2004, Volume: 124, Issue:2

    Topics: Action Potentials; Animals; Arginine; Blood Pressure; Bronchodilator Agents; Drug Interactions; Enzyme Inhibitors; Glutamic Acid; Glycine; Glycine Agents; Homocysteine; Hydrazines; Injections, Spinal; Kidney; Male; Neurons; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; omega-N-Methylarginine; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Spinal Cord; Strychnine; Sympathetic Nervous System; Synapses

2004
Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:9

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Coronary Disease; Enzyme Induction; Homocysteine; Imidazoles; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Myocardium; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Olmesartan Medoxomil; omega-N-Methylarginine; Oxidative Stress; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Superoxides; Tetrazoles; Thiazepines

2004